Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 2674516)

Published in Hum Immunol on February 21, 2009

Authors

Eynav Klechevsky1, Maochang Liu, Rimpei Morita, Romain Banchereau, Luann Thompson-Snipes, A Karolina Palucka, Hideki Ueno, Jacques Banchereau

Author Affiliations

1: Baylor Institute for Immunology Research, Dallas, Texas, USA.

Articles citing this

Designing vaccines based on biology of human dendritic cell subsets. Immunity (2010) 2.04

Harnessing human dendritic cell subsets for medicine. Immunol Rev (2010) 1.46

Leukocyte function in the aging immune system. J Leukoc Biol (2010) 1.32

The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming. Blood (2012) 1.15

Harnessing human dendritic cell subsets to design novel vaccines. Ann N Y Acad Sci (2009) 1.12

Targeting human dendritic cell subsets for improved vaccines. Semin Immunol (2011) 1.09

Dendritic cell-targeted vaccines. Front Immunol (2014) 1.08

Directing dendritic cell immunotherapy towards successful cancer treatment. Immunotherapy (2010) 1.04

Dendritic cells and humoral immunity in humans. Immunol Cell Biol (2010) 0.99

Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response. Viruses (2013) 0.99

Skin-resident antigen-presenting cells: instruction manual for vaccine development. Front Immunol (2013) 0.94

Immunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell priming. Proc Natl Acad Sci U S A (2012) 0.93

Modular expression analysis reveals functional conservation between human Langerhans cells and mouse cross-priming dendritic cells. J Exp Med (2015) 0.92

Dendritic cells: are they clinically relevant? Cancer J (2010) 0.90

Potent induction of antibody-secreting B cells by human dermal-derived CD14+ dendritic cells triggered by dual TLR ligation. J Immunol (2012) 0.88

The ambiguity in immunology. Front Immunol (2012) 0.87

Blood dendritic cells: "canary in the coal mine" to predict chronic inflammatory disease? Front Microbiol (2014) 0.82

Intradermal application of vitamin D3 increases migration of CD14+ dermal dendritic cells and promotes the development of Foxp3+ regulatory T cells. Hum Vaccin Immunother (2013) 0.81

Transcutaneous antigen delivery system. BMB Rep (2013) 0.80

Regulation of Dendritic Cell Function in Inflammation. J Immunol Res (2015) 0.79

Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cells. PLoS One (2013) 0.79

Dendritic cell subsets as vectors and targets for improved cancer therapy. Curr Top Microbiol Immunol (2011) 0.79

In situ Delivery of Antigen to DC-SIGN(+)CD14(+) Dermal Dendritic Cells Results in Enhanced CD8(+) T-Cell Responses. J Invest Dermatol (2015) 0.78

C-type Lectin Receptors for Tumor Eradication: Future Directions. Cancers (Basel) (2011) 0.76

Dendritic cell-based immunotherapy: a basic review and recent advances. Immunol Res (2017) 0.75

Articles cited by this

Dendritic cells and the control of immunity. Nature (1998) 56.54

Pathogen recognition and innate immunity. Cell (2006) 44.14

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med (1992) 22.13

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med (1994) 21.52

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med (1973) 13.88

Tolerogenic dendritic cells. Annu Rev Immunol (2001) 13.77

Taking dendritic cells into medicine. Nature (2007) 11.82

The nature of the principal type 1 interferon-producing cells in human blood. Science (1999) 10.90

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med (2001) 8.60

Differential antigen processing by dendritic cell subsets in vivo. Science (2007) 8.42

Proliferating dendritic cell progenitors in human blood. J Exp Med (1994) 7.67

TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol (2005) 7.44

GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature (1992) 7.41

Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity (2005) 6.48

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev (2006) 6.08

CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med (1999) 6.06

T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol (2008) 5.78

Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A (1999) 5.66

Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol (2003) 5.54

Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity (2003) 5.52

Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity (2007) 5.50

Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity (2006) 5.32

The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med (1997) 5.23

Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science (2003) 5.00

Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol (2008) 4.90

Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol (2001) 4.23

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med (2006) 4.23

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med (2008) 4.21

Identification of a novel population of Langerin+ dendritic cells. J Exp Med (2007) 4.13

Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity (2005) 4.06

Translating innate immunity into immunological memory: implications for vaccine development. Cell (2006) 3.98

Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity (2008) 3.94

Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med (2003) 3.86

Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science (2006) 3.84

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med (1996) 3.82

Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol (2005) 3.75

Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J Exp Med (2007) 3.64

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat Immunol (2002) 3.61

Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med (2003) 3.41

The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med (2007) 3.24

Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J Exp Med (1993) 3.09

Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci U S A (2005) 2.73

Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol (2001) 2.64

Dose-related effects of smallpox vaccine. N Engl J Med (2002) 2.55

Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood (1999) 2.47

Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J Clin Invest (2007) 2.46

The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol (1998) 2.27

Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med (2006) 2.26

The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol (2008) 2.19

Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci U S A (1997) 2.11

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood (1997) 2.06

Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci U S A (2006) 1.98

Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity (2006) 1.95

Cutaneous dendritic cells. Semin Immunol (2005) 1.94

IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells. Proc Natl Acad Sci U S A (2004) 1.92

Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells. J Immunol (2004) 1.77

Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science (2003) 1.73

Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J Clin Invest (1994) 1.71

Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition. J Immunol (2007) 1.55

TNF skews monocyte differentiation from macrophages to dendritic cells. J Immunol (2003) 1.40

Correlates of immune protection and the development of a human immunodeficiency virus vaccine. Immunity (2007) 1.36

Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. Blood (2004) 1.29

Dendritic cells control B cell growth and differentiation. Curr Dir Autoimmun (2005) 1.26

Epidermal Langerhans cells--changing views on their function in vivo. Immunol Lett (2006) 1.18

Identification of CD68+lin- peripheral blood cells with dendritic precursor characteristics. J Immunol (1998) 1.17

Epidermal dendritic cells induce potent antigen-specific CTL-mediated immunity. J Invest Dermatol (1997) 1.02

Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL. Eur J Immunol (2007) 1.01

Cutaneous antigen priming via gene gun leads to skin-selective Th2 immune-inflammatory responses. J Immunol (2005) 0.98

Articles by these authors

Taking dendritic cells into medicine. Nature (2007) 11.82

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med (2003) 11.23

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature (2010) 10.37

Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity (2011) 5.98

A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity (2008) 5.89

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol (2011) 5.39

Cancer immunotherapy via dendritic cells. Nat Rev Cancer (2012) 5.37

Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol (2005) 5.09

Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood (2006) 5.05

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity (2003) 4.93

Pyogenic bacterial infections in humans with MyD88 deficiency. Science (2008) 4.92

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med (2005) 4.79

Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat Immunol (2008) 4.78

Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med (2011) 4.51

Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity (2008) 3.94

Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science (2013) 3.91

Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity (2007) 3.58

Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J Exp Med (2007) 3.51

Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity (2009) 3.13

Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med (2011) 3.12

Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol (2006) 2.99

Tumour immunity: effector response to tumour and role of the microenvironment. Lancet (2008) 2.94

Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat Immunol (2008) 2.82

Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci U S A (2005) 2.73

Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol (2015) 2.70

Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination. Sci Transl Med (2013) 2.64

Autoimmunity through cytokine-induced dendritic cell activation. Immunity (2004) 2.46

Dendritic cell subsets in health and disease. Immunol Rev (2007) 2.45

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers. Clin Cancer Res (2011) 2.44

Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism. J Clin Oncol (2007) 2.35

TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature (2010) 2.31

Dendritic-cell-based therapeutic cancer vaccines. Immunity (2013) 2.29

Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J Exp Med (2007) 2.25

Clinical significance of the mesorectal extension of rectal cancer: a Japanese multi-institutional study. Ann Surg (2011) 2.23

Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology (2009) 2.22

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann Rheum Dis (2010) 2.22

IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice. J Immunol (2005) 2.16

Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev (2008) 2.13

A genomic approach to human autoimmune diseases. Annu Rev Immunol (2010) 2.10

Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity (2013) 2.08

Designing vaccines based on biology of human dendritic cell subsets. Immunity (2010) 2.04

Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol (2009) 2.04

Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metab (2007) 2.00

A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J Immunol (2011) 1.98

Taming cancer by inducing immunity via dendritic cells. Immunol Rev (2007) 1.92

Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat Med (2012) 1.90

Assessing the human immune system through blood transcriptomics. BMC Biol (2010) 1.86

Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLoS One (2013) 1.86

Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development. J Immunol (2010) 1.86

Systemic IFN-alpha drives kidney nephritis in B6.Sle123 mice. Eur J Immunol (2008) 1.84

Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections. PLoS One (2009) 1.79

A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers". J Transl Med (2008) 1.77

Recent developments in cancer vaccines. J Immunol (2011) 1.76

Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity. J Immunother (2006) 1.75

Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood (2005) 1.75

Interferon-α induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZB×NZW)F1 mice but not in BALB/c mice. Eur J Immunol (2011) 1.73

A model for harmonizing flow cytometry in clinical trials. Nat Immunol (2010) 1.70

The central role of dendritic cells and interferon-alpha in SLE. Curr Opin Rheumatol (2003) 1.69

How dendritic cells and microbes interact to elicit or subvert protective immune responses. Curr Opin Immunol (2002) 1.68

Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. PLoS One (2012) 1.68

Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma. Proc Natl Acad Sci U S A (2007) 1.66

Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells. J Virol (2003) 1.64

Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR. Blood (2010) 1.55

Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection. PLoS Med (2013) 1.53

Pretreatment CD133 and cyclooxygenase-2 expression as the predictive markers of the pathological effect of chemoradiotherapy in rectal cancer patients. Dis Colon Rectum (2011) 1.51

Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers. Proc Natl Acad Sci U S A (2011) 1.50

Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells. J Exp Med (2012) 1.50

Humanized mice: are we there yet? J Exp Med (2005) 1.49